Newbridge Financial Services Group’s Dynavax Technologies DVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,000
Closed -$12.8K 1072
2024
Q4
$12.8K Buy
+1,000
New +$12.1K ﹤0.01% 690
2024
Q3
Sell
-1,000
Closed -$11.2K 762
2024
Q2
$11.2K Hold
1,000
﹤0.01% 686
2024
Q1
$12.4K Hold
1,000
0.01% 712
2023
Q4
$14K Hold
1,000
0.01% 668
2023
Q3
$14.8K Hold
1,000
0.01% 716
2023
Q2
$12.9K Hold
1,000
0.01% 827
2023
Q1
$9.81K Hold
1,000
0.01% 917
2022
Q4
$10.6K Hold
1,000
0.01% 904
2022
Q3
$10K Hold
1,000
0.01% 876
2022
Q2
$13K Hold
1,000
0.01% 778
2022
Q1
$11K Hold
1,000
0.01% 908
2021
Q4
$14K Hold
1,000
0.01% 831
2021
Q3
$19K Hold
1,000
0.01% 673
2021
Q2
$10K Hold
1,000
0.01% 981
2021
Q1
$10K Buy
+1,000
New +$8.24K 0.01% 894

Other funds holding DVAX

Newbridge Financial Services Group's DVAX Position: Q1 2025 in Review

Newbridge Financial Services Group sold out of Dynavax Technologies (DVAX) in Q1 2025, closing a stake of 1,000 shares — an estimated $12.8K sold.

Newbridge Financial Services Group first reported a position in DVAX in Q1 2021 and held it in 15 quarters. The position peaked at $19K in Q3 2021. 284 funds tracked by Wall St. Rank hold DVAX as of Q1 2025.

  • Newbridge Financial Services Group reported no remaining Dynavax Technologies position as of Q1 2025 after selling out during the quarter.
  • Newbridge Financial Services Group sold 1,000 Dynavax Technologies shares in Q1 2025, an estimated $12.8K.
  • Newbridge Financial Services Group first reported a position in Dynavax Technologies in Q1 2021 and held it in 15 quarters.
  • Newbridge Financial Services Group's Dynavax Technologies position peaked at $19K in Q3 2021.
  • 284 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2025.

Based on Newbridge Financial Services Group's 13F filing for Q1 2025, filed 15 May 2025.